0 Valutazioni
ID

20421

Descrizione

The purpose of the trial is to determine if extended-release dipyridamole + aspirin [Aggrenox, Asasa ntin] is superior to clopidogrel [Plavix], and if telmisartan [Micardis, Gliosartan, Kinzal, Kinzalm ono, Predxal, Pritor, Samertan, Telmisartan] is superior to placebo, in the presence of background antihypertensive therapy, in prevention of a second stroke in patients who have recently suffered a stroke and therefore are at high risk of suffering another one. Source & Descriptions: https://clinicaltrials.gov/ct2/show/NCT00153062?term=NCT00153062&rank=1

collegamento

https://clinicaltrials.gov/ct2/show/NCT00153062?term=NCT00153062&rank=1

Keywords

versioni (1)
  1. 22/02/17 22/02/17 -
Caricato su

22 febbraio 2017

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

  • i più nuovi
  • i più vecchi
  • Popolare
  • i più nuovi
    • i più nuovi
    • i più vecchi
    • Popolare

    Non ci sono commenti

    Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

    Trial Completion PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

    Inglese

    Trial Completion PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

    1 moduli  
    Trial Completion
    Descrizione

    Trial Completion

    Alias
    UMLS CUI-1
    C2732579 (Completion of clinical trial)
    SNOMED
    443729008
    1. The patient completed planned observation time according to protocol
    Descrizione

    patient completed planned observation time

    Tipo di dati

    boolean

    Alias
    UMLS CUI [1,1]
    C0525058 (Protocol Compliance)
    UMLS CUI [1,2]
    C0040223 (Time)
    SNOMED
    410670007
    LOINC
    LP73517-2
    2. If no please specify why:
    Descrizione

    if no

    Tipo di dati

    integer

    Alias
    UMLS CUI [1]
    C2348235 (Specification)
    Explain:
    Descrizione

    Explanation

    Tipo di dati

    text

    Alias
    UMLS CUI [1]
    C0681841 (Explanation)
    LOINC
    LA15331-4
    Invenstigator´s Declaration
    Descrizione

    Invenstigator´s Declaration

    Alias
    UMLS CUI-1
    C0008961 (Clinical Investigators)
    3. Invenstigator´s Declaration By signing and dating this page, I declare that I have reviewed for accuracy all case report form pages for this patient; the information contained on these pages accurately reflects the medical record including the results of tests and evaluations performed in the dates specified.
    Descrizione

    Invenstigator´s Declaration

    Tipo di dati

    text

    Alias
    UMLS CUI [1,1]
    C0008961 (Clinical Investigators)
    UMLS CUI [1,2]
    C1442085 (Instructions)
    LOINC
    LP6820-7
    Investigator´s signature
    Descrizione

    Investigator´s signature

    Tipo di dati

    text

    Alias
    UMLS CUI [1]
    C2346576 (Investigator Signature)
    Date of Signature
    Descrizione

    Date of Signature

    Tipo di dati

    date

    Alias
    UMLS CUI [1,1]
    C0011008 (Date in time)
    SNOMED
    410671006
    UMLS CUI [1,2]
    C1519316 (Signature)
    LOINC
    LP248948-4
    Ritorna all'inizio della pagina

    Similar models

    Trial Completion PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

    1 moduli
    Name
    genere
    Description | Question | Decode (Coded Value)
    Tipo di dati
    Alias
    Item Group
    Trial Completion
    C2732579 (UMLS CUI-1)
    patient completed planned observation time
    Item
    1. The patient completed planned observation time according to protocol
    boolean
    C0525058 (UMLS CUI [1,1])
    C0040223 (UMLS CUI [1,2])
    Item
    2. If no please specify why:
    integer
    C2348235 (UMLS CUI [1])
    if no
    Code List
    2. If no please specify why:
    CL Item
    Death (must me recorded on death form) (1)
    CL Item
    Adverse Event (explain below) (2)
    CL Item
    Non compliant with protocol (explain below) (3)
    CL Item
    Lost follow-up (explain below) (4)
    CL Item
    Consent withdrawn (not due to adverse event, explain below) (5)
    CL Item
    Other (explain below) (6)
    Explanation
    Item
    Explain:
    text
    C0681841 (UMLS CUI [1])
    Item Group
    Invenstigator´s Declaration
    C0008961 (UMLS CUI-1)
    Invenstigator´s Declaration
    Item
    3. Invenstigator´s Declaration By signing and dating this page, I declare that I have reviewed for accuracy all case report form pages for this patient; the information contained on these pages accurately reflects the medical record including the results of tests and evaluations performed in the dates specified.
    text
    C0008961 (UMLS CUI [1,1])
    C1442085 (UMLS CUI [1,2])
    Investigator´s signature
    Item
    Investigator´s signature
    text
    C2346576 (UMLS CUI [1])
    Date of Signature
    Item
    Date of Signature
    date
    C0011008 (UMLS CUI [1,1])
    C1519316 (UMLS CUI [1,2])
    Ritorna all'inizio della pagina 

    Aiuto

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial